We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    LDX0419
Previous Study | Return to List | Next Study

A Study to Assess Efficacy/Safety of Ladarixin in Type 1 Diabetes Patients With Preserved ß-cell Function at Baseline.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04899271
Recruitment Status : Active, not recruiting
First Posted : May 24, 2021
Last Update Posted : May 3, 2022
Information provided by (Responsible Party):
Dompé Farmaceutici S.p.A

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : June 2023
Estimated Study Completion Date : December 2023